TD Cowen expressed concerns about valuation. “If Celsius can’t demonstrate a path back to growth, it could end up being ...

Fintel reports that on January 21, 2025, TD Cowen initiated coverage of Forte Biosciences (NasdaqCM:FBRX) with a Buy ...

TD Cowen analyst Ritu Baral maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) today and set a price target of $9.00. The ...

The rise in targets in recent days, however, pushes the stock toward $360 after UBS Group raised its target on Salesforce and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.31% of ...

Celsius Holdings (NASDAQ:CELH) swung lower in early trading on Wednesday after TD Cowen downgraded the energy drink stock to a Hold rating after having it set at Buy. Notably, the firm's retail ...

Exxon Mobil Corp (XOM) stock saw a modest uptick, ending the day at $112.32 which represents a slight increase of $1.00 or 0.90% from the prior close of $111.32. The stock opened at $111.03 and ...

Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE: COP) with a "Buy" rating and a $125 price target, ...

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE:COP) with a "Buy" rating and a $125 price target, noting its vast asset base, low-cost operations, and long-term growth drivers ...

TD Cowen upgraded Blue Owl Capital (OWL) to Buy from Hold with a price target of $28, up from $26, ahead of the company’s investor day on ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...